Avalon Pharma Q4 2025 earnings: Analyst forecasts

Last Updated Date (19/02/2026) Argaam Report

Argaam highlights the expected results of Middle East Pharmaceutical Industries Co. (Avalon Pharma) for Q4 2025, its key events, sales, performance indicators, and profitability.

 

Revenues are likely to grow 5.08% year-on-year (YoY)

To Access this Content, Please Login Or Register

To Access this Content, Please Login or Subscribe
Contact Us (+966)-92000-7759